NDC 75007-041-01 - Paclitaxel
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 75007-041
- Requested NDC
- 75007-041-01
- Package NDCs from labels
- 75007-041-01
- Manufacturer
- Ningbo Shuangcheng Pharmaceutical Co., Ltd | Ningbo Shuangcheng Pharmaceuticals Co.,Ltd
- Effective date
- 2026-02-11
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Paclitaxel - Ningbo Shuangcheng Pharmaceutical Co., Ltd | Ningbo Shuangcheng Pharmaceuticals Co.,Ltd | Ningbo Shuangcheng Pharmaceutical Co., Ltd | Ningbo Shuangcheng Pharmaceuticals Co.,Ltd | 2026-02-11 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 75007-041-01 | Paclitaxel | 1 in 1 CARTON | INJECTION, POWDER, LYOPHILIZED, | 1 | 5 | |
| 75007-041-01 | Paclitaxel | 100 mg in 1 VIAL, SINGLE-DOSE | INJECTION, POWDER, LYOPHILIZED, | 100 | 5 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Paclitaxel | PACLITAXEL | Alembic Pharmaceuticals Inc. | 0c12c77c-5fd4-48dc-a318-e96892233992 | 2024-06-24 | Boxed warning, Warnings, Adverse reactions | P88XT4IS4D |
| Paclitaxel | PACLITAXEL | Sagent Pharmaceuticals | 5721b9bf-c3c1-4b73-b96c-5fbe3147b6a5 | 2024-01-20 | Boxed warning, Warnings, Adverse reactions | P88XT4IS4D |
| Paclitaxel | PACLITAXEL | Teva Pharmaceuticals, Inc. | 15dd51ed-29e8-468b-b6d1-21b1f84d6f2e | 2023-11-01 | Boxed warning, Warnings, Adverse reactions | 583214 P88XT4IS4D |
| PACLITAXEL PROTEIN BOUND PARTICLES ALBUMIN BOUND | PACLITAXEL | American Regent, Inc. | f06d1bb3-83f1-4d84-8004-4c6681ad8a5a | 2023-05-01 | Boxed warning, Warnings, Adverse reactions | 583214 P88XT4IS4D |
| Paclitaxel | PACLITAXEL | Alembic Pharmaceuticals Limited | 6d04b514-c85c-4db1-919e-21dd98172791 | 2023-01-31 | Boxed warning, Warnings, Adverse reactions | P88XT4IS4D |
| ABRAXANE | PACLITAXEL | Abraxis BioScience, LLC | 24d10449-2936-4cd3-b7db-a7683db721e4 | 2022-10-31 | Boxed warning, Warnings, Adverse reactions | 583214 P88XT4IS4D |
| Paclitaxel | PACLITAXEL | Northstar Rx LLC | e47c2c34-0466-4219-be6f-97e4231ed55f | 2021-01-25 | Boxed warning, Warnings, Adverse reactions | P88XT4IS4D |
| Paclitaxel | PACLITAXEL | Novadoz Pharmaceuticals LLC | 4e1bf850-d616-4ff3-b62a-2057dddc3dfe | 2020-08-25 | Boxed warning, Warnings, Adverse reactions | P88XT4IS4D |
| PACLITAXEL PACLITAXEL | PACLITAXEL | Gland Pharma Limited | fec9ddee-53a9-4a61-ad0a-be6b604de084 | 2016-09-01 | Boxed warning, Warnings, Adverse reactions | P88XT4IS4D |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.